Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
MasterPharm LLC is recalling Tadalafil 26 mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling D-Biotin 300 mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling Progesterone 50 mg Modified Release Capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling 600 capsules of Progesterone Modified Release 100 mg due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling Testosterone/Anastrozole Pellets 100/6 mg due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling Yohimbine HCL 5.4mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
Sun Pharmaceutical is recalling Clonazepam Orally Disintegrating Tablets because routine stability testing detected cross-contamination with clozapine.
MasterPharm LLC is recalling Minoxidil/Biotin/Spironolactone capsules nationwide due to a lack of processing controls and assurance of conformity to specifications.
MasterPharm LLC is recalling Tadalafil 7 mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling specific lots of Progesterone 150 mg Troches nationwide due to a lack of processing controls that ensures conformity to specifications.
MasterPharm LLC is recalling Minoxidil/Biotin 1.25mg/5mg capsules nationwide due to a lack of processing controls that ensures conformity to specifications.
Allergan is recalling 8,555 Skin Medica Acne System kits nationwide because the products failed potency tests at 12 and 24 months.
Transliquid Technologies is recalling Mystic Shield hand sanitizer bottles due to the presence of undeclared methanol.
Lupin Pharmaceuticals is recalling Cefdinir for Oral Suspension due to out-of-specification assay results in retention samples.
Walker Emulsions Inc. is recalling Walker Hand Sanitizer because it contains DA-2I Ethanol, an excipient not approved for use in hand sanitizers.
Walker Emulsions Inc. is recalling 1-gallon bottles of 60% hand sanitizer because it contains an unapproved excipient, DA-2I Ethanol.
HF Acquisition Co. LLC is recalling specific lots of Famotidine Injection because a customer reported the product was received in a non-refrigerated state.
Lupin Pharmaceuticals is recalling Metformin Hydrochloride Extended-release Tablets because FDA analysis detected NDMA impurity above acceptable intake levels.
Granules Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets due to FDA detection of N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels.
Lupin Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Lupin Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Lupin Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
RemedyRepack Inc. is recalling Carbamazepine 200 mg tablets because routine stability testing revealed low dissolution results.
Akorn, Inc. is recalling Proparacaine Hydrochloride Ophthalmic Solution, 0.5%, due to chemical contamination from equipment cleaning residue.
Preferred Pharmaceuticals is recalling Lidothol Patches because the contract manufacturer misplaced or lost batch records and test results.